We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+34.77%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.54B
AUM Growth
-$138M
(-8.2%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-19.47%
Top 10 Holdings %
Top 10 Hldgs %
9.99%
Holding
2,498
New
653
Increased
404
Reduced
598
Closed
777
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CY
Cypress Semiconductor
CY
|
+$17M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$15M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$14.8M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$11.6M |
| 5 |
CZR
Caesars Entertainment Corporation
CZR
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.77M |
| 2 |
Cigna
CI
|
+$2.57M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.48M |
| 4 |
Baidu
BIDU
|
+$2.2M |
| 5 |
Bausch Health
BHC
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.98% |
| 2 | Technology | 4.63% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Industrials | 1.77% |
| 5 | Financials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPO
26
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $6.35M | 0.41% |
54,600
+42,000
| +333% | +$4.86M |
|
27
CALL
Teradyne
TER
$54.8B
| $6.31M | 0.41% |
92,500
+17,600
| +23% | +$1.12M |
|
28
PUT
Bristol-Myers Squibb
BMY
$127B
| $6.19M | 0.4% |
96,400
+17,700
| +22% | +$1.01M |
|
|
TIF
29
DELISTED
Tiffany & Co.
TIF
| $5.96M | 0.39% |
+44,626
| New | +$5.27M |
|
30
CALL
Visa
V
$677B
| $5.92M | 0.38% |
31,500
+26,900
| +585% | +$4.85M |
|
31
CALL
Agnico Eagle Mines
AEM
$72.6B
| $5.81M | 0.38% |
94,300
+15,400
| +20% | +$894K |
|
32
PUT
Hasbro
HAS
$12.6B
| $5.79M | 0.38% |
54,800
+53,600
| +4,467% | +$5.58M |
|
|
EE
33
DELISTED
El Paso Electric Company
EE
| $5.69M | 0.37% |
+83,828
| New | +$5.65M |
|
34
CALL
Charter Communications
CHTR
$14.7B
| $5.58M | 0.36% |
+11,500
| New | +$5.29M |
|
35
CALL
Eli Lilly
LLY
$1.07T
| $5.57M | 0.36% |
42,400
-74,500
| -64% | -$8.64M |
|
|
BIG
36
CALL
DELISTED
Big Lots, Inc.
BIG
| $5.56M | 0.36% |
193,600
+40,700
| +27% | +$939K |
|
37
CALL
United Rentals
URI
$71.1B
| $5.44M | 0.35% |
32,600
+5,800
| +22% | +$842K |
|
|
38
PUT
Agnico Eagle Mines
AEM
$72.6B
| $5.41M | 0.35% |
87,800
+64,200
| +272% | +$3.73M |
|
39
PUT
Biogen
BIIB
$29.9B
| $5.37M | 0.35% |
18,100
-9,100
| -33% | -$2.52M |
|
40
CALL
Tyson Foods
TSN
$20.2B
| $5.26M | 0.34% |
57,800
+25,000
| +76% | +$2.15M |
|
41
CALL
Sempra
SRE
$60.8B
| $5.26M | 0.34% |
69,400
-31,200
| -31% | -$2.29M |
|
42
CALL
Archer Daniels Midland
ADM
$41.4B
| $5.07M | 0.33% |
109,400
-130,200
| -54% | -$5.55M |
|
43
CALL
United Parcel Service
UPS
$97.6B
| $4.95M | 0.32% |
+42,300
| New | +$5.01M |
|
44
PUT
Berkshire Hathaway Class B
BRK.B
$1.07T
| $4.76M | 0.31% |
+21,000
| New | +$4.56M |
|
45
CALL
Universal Health Services
UHS
$9.43B
| $4.73M | 0.31% |
+33,000
| New | +$4.7M |
|
|
PRAH
46
CALL
DELISTED
PRA Health Sciences, Inc.
PRAH
| $4.71M | 0.31% |
42,400
+15,800
| +59% | +$1.63M |
|
47
CALL
Chevron
CVX
$388B
| $4.66M | 0.3% |
38,700
+33,400
| +630% | +$3.93M |
|
|
ALXN
48
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.63M | 0.3% |
42,800
+42,200
| +7,033% | +$4.51M |
|
|
49
PUT
Cigna
CI
$76.6B
| $4.62M | 0.3% |
22,600
-8,400
| -27% | -$1.54M |
|
50
CALL
Cars.com
CARS
$641M
| $4.62M | 0.3% |
378,000
-24,800
| -6% | -$289K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Walleye Capital held 2,498 positions worth $1.54B, down 8.2% from $1.68B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Walleye Capital withdrew a net $300M in Q4 2019, closing 777 positions and reducing 598 holdings. Its most notable exit was Cigna, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 5% of assets, up from 1.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Walleye Capital opened a new position in Cypress Semiconductor worth $17M.
- Walleye Capital's largest Q4 2019 buy was Cypress Semiconductor: 727,918 shares worth $17M.
- Walleye Capital added most to Acacia Communications Inc in Q4 2019, an estimated $8.45M increase.
- Walleye Capital's biggest Q4 2019 reduction was Humana, cutting an estimated $2.77M.
- Walleye Capital fully exited Cigna in Q4 2019, selling an estimated $2.57M.
- Walleye Capital's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2019.
- Walleye Capital opened 653 new positions and closed 777 in Q4 2019.
- Walleye Capital's portfolio value fell 8.2% quarter-over-quarter to $1.54B.
Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.